Gynecologic Cancer InterGroup (GCIG) consensus review for ovarian small cell cancers.

TitleGynecologic Cancer InterGroup (GCIG) consensus review for ovarian small cell cancers.
Publication TypeJournal Article
Year of Publication2014
AuthorsReed, NSimon, Pautier, P, Ă…vall-Lundqvist, E, Choi, C-H, du Bois, A, Friedlander, MLeonard, Fyles, A, Kichenadasse, G, Provencher, DM, Ray-Coquard, I
JournalInt J Gynecol Cancer
Issue9 Suppl 3
Date Published11/2014
KeywordsCarcinoma, Small Cell, Combined Modality Therapy, Consensus, Female, Humans, Medical Oncology, Ovarian Neoplasms, Practice Guidelines as Topic, Societies, Medical

Small cell carcinomas of the ovary are uncommon and account for less than 1% of ovarian cancers. They were first recognized in 1979, and a number of reports appeared during the next 2 decades. They are highly aggressive tumors and usually carry a poor prognosis, although this may reflect that most are diagnosed at advanced stage; however, those diagnosed as stage 1A have only 30% to 40% of long-term survivors. More reports followed extending our experience in the diagnosis and management of these rare cancers. The classification is described below and shown in Table 1, but a revision is expected to be published from the World Health Organization in 2014.

Alternate JournalInt. J. Gynecol. Cancer
PubMed ID25341577